Globus Medical (GMED)Artemis Investment Management LLP reduced its stake -275K shares

573K

Shares reported · -275K vs prior quarter

0.40%

Disclosed portfolio weight

$45.3M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 27, 2026Federal contract · $33K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $33K obligated to date
2. Jun 3, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 3, 2026, Globus Medical, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) at which the Company’s stockholders approved an amendment (the “2021 Equity Incentive Plan Amendment”) to the Globus Medical, Inc. 2021 Equity Incentive Plan (the “Plan”) to increase the number of shares authorized thereunder by 1,000,000 (the Plan as amended by the 2021 Equity Incentive Plan…”
3. Jun 5, 2026InsiderDirector sold ~$2.02M of GMED shares in the open market
4. Jun 25, 2026Federal contract · $24K obligatedDepartment of Defense awarded GLOBUS MEDICAL INC: $24K obligated to date

What came next

1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
2. Aug 18, 2026InsiderDirector sold ~$2.18M of GMED shares in the open market
3. Aug 19, 2026CongressDisclosed purchase of GMED — reported range $15,001 - $50,000
4. Sep 15, 2026Insider · Their largest sale since 2019Director sold ~$2.24M of GMED shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Globus Medical

For Globus Medical, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 12 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GMED page.

How this filing works

• SEC Form 13F

Other disclosures at Globus Medical

• SEC Form 4Sep 16, 2026
• House Clerk periodic transaction reportSep 10, 2026
• USAspending.gov award recordAug 20, 2026
• SEC Form 4Aug 19, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its GMED page.